Digoxin vs Rituximab

Digoxin vs Rituximab: Overview

This comparison examines the pharmacological differences between Digoxin and Rituximab.

Mechanism of Action

Digoxin: Inhibits Na+/K+-ATPase, increasing intracellular calcium.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Digoxin — 36-48 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Digoxin — C41H64O14.

Molecular Weight: Digoxin — 780.9430 g/mol.

Type: Digoxin — Small molecule; Rituximab — Antibody.